| For: | Santantonio TA, Fasano M. Chronic hepatitis B: Advances in treatment. World J Hepatol 2014; 6(5): 284-292 [PMID: 24868322 DOI: 10.4254/wjh.v6.i5.284] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i5/284.htm |
| Number | Citing Articles |
| 1 |
Antje Blank, Christoph Markert, Nicolas Hohmann, Alexandra Carls, Gerd Mikus, Thorsten Lehr, Alexander Alexandrov, Mathias Haag, Matthias Schwab, Stephan Urban, Walter E. Haefeli. First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B. Journal of Hepatology 2016; 65(3) doi: 10.1016/j.jhep.2016.04.013
|
| 2 |
Guo Qing Yin, Bei Zhong. Efficacy of interferon for chronic hepatitis B in patients with nucleoside and nucleotide combination therapy failure. Journal of Gastroenterology and Hepatology 2016; 31(1) doi: 10.1111/jgh.13191
|
| 3 |
Yang Ke, Lin Wang, Le-Qun Li, Jian-Hong Zhong. Nucleos(t)ide analogues to treat hepatitis B virus-related hepatocellular carcinoma after radical resection. World Journal of Hepatology 2014; 6(9): 652-659 doi: 10.4254/wjh.v6.i9.652
|
| 4 |
Jeong Han Kim, Ji Wan Kim, Jung Woong Seo, Won Hyeok Choe, So Young Kwon. Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. Journal of Clinical Gastroenterology 2016; 50(10) doi: 10.1097/MCG.0000000000000574
|
| 5 |
Lei Jiang, Xiaohua Wu, Fang He, Ying Liu, Xiaoqing Hu, Shunichi Takeda, Yong Qing, Michael R Volkert. Genetic Evidence for Genotoxic Effect of Entecavir, an Anti-Hepatitis B Virus Nucleotide Analog. PLOS ONE 2016; 11(1) doi: 10.1371/journal.pone.0147440
|
| 6 |
Jia‐Horng Kao, Tarik Asselah, Xiao‐Guang Dou, Kamal Hamed. Telbivudine therapy for chronic hepatitis B: A journey to identify super‐responders and to optimize treatment using the roadmap model. Journal of Gastroenterology and Hepatology 2017; 32(1) doi: 10.1111/jgh.13512
|
| 7 |
Maren Gebbing, Thorsten Bergmann, Eric Schulz, Anja Ehrhardt. Gene therapeutic approaches to inhibit hepatitis B virus replication. World Journal of Hepatology 2015; 7(2): 150-164 doi: 10.4254/wjh.v7.i2.150
|
| 8 |
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, Paola Begini, Michela Ileen Biondo, Sara Caporuscio, Vincenzo Colonna, Francesca Della Casa, Paola Conigliaro, Cinzia Marrese, Eleonora Celletti, Irene Modesto, Mario Stefano Peragallo, Bruno Laganà, Andrea Picchianti-Diamanti, Roberta Di Rosa, Claudia Ferlito, Simonetta Salemi, Raffaele D’Amelio, Tommaso Stroffolini. Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy. Microorganisms 2020; 8(11) doi: 10.3390/microorganisms8111792
|
| 9 |
Ai Peng, Khalid Waleed, Liping Qiu, Li Wang, Xiaoqin Tong, Zhibin Tu, Zhikang Li, Yiting Cui, Fei Hu, Shu Yang, Liang Lu, Peng Huang. Immunological research landscapes and emerging immune mechanisms in HIV/HBV co-infection: a bibliometric analysis (2014–2024). Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1807430
|
| 10 |
Maheeba Abdulla, Mohamed Ghuloom, Hafsa Nass, Nafeesa Mohammed, Eman Farid, Jehad ALQamish. Prevalence of hepatitis B e antigenemia in Bahraini hepatitis B patients: A retrospective, single‐center study. JGH Open 2021; 5(3) doi: 10.1002/jgh3.12494
|
| 11 |
Waled Mohsen, Miriam T. Levy. Hepatitis A to E: what's new?. Internal Medicine Journal 2017; 47(4) doi: 10.1111/imj.13386
|
| 12 |
Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick Arbuthnot. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection. Advanced Drug Delivery Reviews 2021; 168 doi: 10.1016/j.addr.2020.05.010
|
| 13 |
Michael R. Charlton, Altaf Alam, Akash Shukla, Bekhbold Dashtseren, Cosmas Rinaldi Adithya Lesmana, Davadoorj Duger, Diana Alcantara Payawal, Do Duy Cuong, Ganbolor Jargalsaikhan, Ian Homer Yee Cua, Jose Decena Sollano, Karam Romeo Singh, Kaushal Madan, Khin Maung Win, Khin Pyone Kyi, Kyaw Soe Tun, Mohd. Salih, Mukul Rastogi, Neeraj Saraf, Pham Thi Thu Thuy, Pham Tran Dieu Hien, Rino Alvani Gani, Rosmawati Mohamed, Tawesak Tanwandee, Teerha Piratvisuth, Wattana Sukeepaisarnjaroen, Win Naing, Zahid Yasin Hashmi. An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia. Journal of Gastroenterology 2020; 55(9) doi: 10.1007/s00535-020-01698-4
|
| 14 |
Jia-Li Wang, Xin-Fang Du, Shao-Long Chen, Yi-Qi Yu, Jing Wang, Xi-Qi Hu, Ling-Yun Shao, Jia-Zhen Chen, Xin-Hua Weng, Wen-Hong Zhang. Histological outcome for chronic hepatitis B patients treated with entecavir <italic>vs</italic> lamivudine-based therapy. World Journal of Gastroenterology 2015; 21(32): 9598-9606 doi: 10.3748/wjg.v21.i32.9598
|
| 15 |
Cihan Semet. Naif Kronik Hepatit B Tedavisinde Tenofovir Alafenamid: Tek Merkezli Retrospektif Çalışma. ANKEM Dergisi 2024; 38(1) doi: 10.54962/ankemderg.1413377
|
| 16 |
Sara G. Fonseca, Fabian M. Cortés-Mancera, Marianne G. Rots, Federica Sarno, Marleen van der Laan. The promise of epigenetic editing strategies in functionally curing chronic hepatitis B virus infections. Epigenetics Communications 2026; 6(1) doi: 10.1186/s43682-025-00041-3
|
| 17 |
Limia Abueldahab, Yadarat Suwanmanee, Nelly Muriungi, Eriko Ohsaki, Masami Wada, Shihoko Kimura‐Ohba, Keiji Ueda. Analysis of the Functional Role of TIMM29 in the Hepatitis B Virus Life Cycle. Microbiology and Immunology 2025; 69(4) doi: 10.1111/1348-0421.13206
|
| 18 |
Mi Na Kim, Ju Ho Lee, Young Eun Chon, Yeonjung Ha, Seong Gyu Hwang. Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy. European Journal of Gastroenterology & Hepatology 2020; 32(3) doi: 10.1097/MEG.0000000000001520
|
| 19 |
Iain A. Gillespie, K. Arnold Chan, Yunhao Liu, Shu-Feng Hsieh, Christian Schindler, Wendy Cheng, Rose Chang, Elisabeth Kap, Eleonora Morais, Mei Sheng Duh, Suna Park, Miriam Ketz, Sarah Jenner, Naomi Boxall, Stuart Kendrick, Dickens Theodore. Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database Study. Advances in Therapy 2023; 40(2) doi: 10.1007/s12325-022-02284-1
|
| 20 |
T. P. Ospelnikova, E. M. Noseikina, L. A. Gaiderova, F. I. Ershov. THERAPEUTIC POTENTIAL OF ALPHA-INTERFERON PREPARATIONS DURING SOCIALLY-SIGNIFICANT HUMAN DISEASES OF VIRAL ETIOLOGY. Journal of microbiology, epidemiology and immunobiology 2016; 93(5) doi: 10.36233/0372-9311-2016-5-109-121
|
| 21 |
Giordano Madeddu, Silvia Ortu, Giovanni Garrucciu, Ivana Maida, Michela Melis, Alberto Augusto Muredda, Maria Stella Mura, Sergio Babudieri. DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long‐term nucleo(t)side analogs therapy. Journal of Medical Virology 2017; 89(7) doi: 10.1002/jmv.24742
|
| 22 |
Seyed Moayed Alavian, Alireza Showraki. Hepatitis B and its Relationship With Oxidative Stress. Hepatitis Monthly 2016; 16(9) doi: 10.5812/hepatmon.37973
|
| 23 |
R. Orlando, M. Foggia, A. E. Maraolo, S. Mascolo, G. Palmiero, O. Tambaro, G. Tosone. Prevention of hepatitis B virus infection: from the past to the future. European Journal of Clinical Microbiology & Infectious Diseases 2015; 34(6) doi: 10.1007/s10096-015-2341-x
|
| 24 |
Man Yuan, Wenzhen Wang, Han Chen, Jiajie Lu, Min He, Cong Liu, Hong Tang, Lichun Wang. ABCC4, ABCC5 and SLC28A1 Polymorphisms: Host Genome on Responses of Chronic Hepatitis B Patients with Entecavir Treatment. Antiviral Therapy 2016; 21(8) doi: 10.3851/IMP3063
|
| 25 |
Sheiliza Carmali, Hironobu Murata, Chad Cummings, Krzysztof Matyjaszewski, Alan J. Russell. NanoArmoring of Enzymes: Rational Design of Polymer-Wrapped Enzymes. Methods in Enzymology 2017; 590 doi: 10.1016/bs.mie.2016.12.005
|
| 26 |
Yi-Chang Liu, Chi-Mu Hsu, Samuel Yien Hsiao, Hui-Hua Hsiao. Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Personalized Medicine 2021; 11(11) doi: 10.3390/jpm11111108
|
| 27 |
Meixuan Li, Liang Yao, Yu Qin, Yanfei Li, Mengying Lu, Mina Ma, Minyan Yang, Ke Guo, Qi Wang, Zhichun Zhang, LongDong Zhu, Xiuxia Li, Kehu Yang. Tenofovir versus entecavir for children and adults with chronic hepatitis B. Cochrane Database of Systematic Reviews 2023; 2023(9) doi: 10.1002/14651858.CD015642
|